Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bevacizumab, 5-FU, and Radiation in Rectal Cancer
NCT00308516Phase 2Completed
- Sponsor
- SCRI Development Innovations
- Start
- Mar 2006
- Primary completion
- Apr 2009
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in rectal cancer, sponsored by SCRI Development Innovations. Started Mar 2006; status: completed.
02
Drugs
bevacizumab
03
Conditions
rectal cancer
Beyond the preview
Go deeper on NCT00308516.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00308516.